Sensei Biotherapeutics, Inc. Common Stock
Symbol: SNSE (NASDAQ)
10.64
▼ (-5.00%) -0.560
Company Description:
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
Key Stats
- Today's Open: $11.09
- Today's High: $11.275
- Today's Low: $10.36
- Today's Volume: 14.55K
- Yesterday Close: $11.2
- Yesterday High: $11.6
- Yesterday Low: $10
- Yesterday Volume: 22.98K
- Last Min Volume: 2
- Last Min High: $10.64
- Last Min Low: $10.64
- Last Min VWAP: $10.64
Company Profile
- Name: Sensei Biotherapeutics, Inc. Common Stock
- Website: https://www.senseibio.com
- Listed Date: 2021-02-04
- Location: ROCKVILLE, MD
- Market Status: Active
- CIK Number: 0001829802
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $14.13M
- Round Lot: 100
- Outstanding Shares: 1.26M
- Asset Type: CS
RECENT FILINGS FOR SNSE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | 8-K | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-09 | 8-K | View |
| 2025-06-13 | 8-K | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 8-K | View |
| 2025-05-06 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-04-11 | ARS | View |
| 2025-04-11 | DEFA14A | View |
| 2025-04-11 | DEF 14A | View |
| 2025-04-01 | PRE 14A | View |
| 2025-03-28 | S-8 | View |
| 2025-03-28 | 10-K | View |
Latest News on SNSE